These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31956991)

  • 21. Interaction of cell culture process parameters for modulating mAb afucosylation.
    Nguyen Dang A; Mun M; Rose CM; Ahyow P; Meier A; Sandoval W; Yuk IH
    Biotechnol Bioeng; 2019 Apr; 116(4):831-845. PubMed ID: 30597531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of depth filtration on disulfide bond reduction during downstream processing of monoclonal antibodies from CHO cell cultures.
    O'Mara B; Gao ZH; Kuruganti M; Mallett R; Nayar G; Smith L; Meyer JD; Therriault J; Miller C; Cisney J; Fann J
    Biotechnol Bioeng; 2019 Jul; 116(7):1669-1683. PubMed ID: 30883673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody disulfide bond reduction and recovery during biopharmaceutical process development-A review.
    Ren T; Tan Z; Ehamparanathan V; Lewandowski A; Ghose S; Li ZJ
    Biotechnol Bioeng; 2021 Aug; 118(8):2829-2844. PubMed ID: 33844277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of media and antifoam selection on monoclonal antibody production and quality using a high throughput micro-bioreactor system.
    Velugula-Yellela SR; Williams A; Trunfio N; Hsu CJ; Chavez B; Yoon S; Agarabi C
    Biotechnol Prog; 2018 Jan; 34(1):262-270. PubMed ID: 29086492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A control strategy to investigate the relationship between specific productivity and high-mannose glycoforms in CHO cells.
    Zalai D; Hevér H; Lovász K; Molnár D; Wechselberger P; Hofer A; Párta L; Putics Á; Herwig C
    Appl Microbiol Biotechnol; 2016 Aug; 100(16):7011-24. PubMed ID: 26910040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of antibody reduction in cell culture production processes.
    Kao YH; Hewitt DP; Trexler-Schmidt M; Laird MW
    Biotechnol Bioeng; 2010 Nov; 107(4):622-32. PubMed ID: 20589844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cysteine in cell culture media induces acidic IgG1 species by disrupting the disulfide bond network.
    Prade E; Zeck A; Stiefel F; Unsoeld A; Mentrup D; Arango Gutierrez E; Gorr IH
    Biotechnol Bioeng; 2021 Mar; 118(3):1091-1104. PubMed ID: 33200817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a scale down cell culture model using multivariate analysis as a qualification tool.
    Tsang VL; Wang AX; Yusuf-Makagiansar H; Ryll T
    Biotechnol Prog; 2014; 30(1):152-60. PubMed ID: 24124180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Culture temperature modulates aggregation of recombinant antibody in cho cells.
    Gomez N; Subramanian J; Ouyang J; Nguyen MD; Hutchinson M; Sharma VK; Lin AA; Yuk IH
    Biotechnol Bioeng; 2012 Jan; 109(1):125-36. PubMed ID: 21965146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells.
    Figueroa B; Ailor E; Osborne D; Hardwick JM; Reff M; Betenbaugh MJ
    Biotechnol Bioeng; 2007 Jul; 97(4):877-92. PubMed ID: 17099908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effects.
    Hutterer KM; Hong RW; Lull J; Zhao X; Wang T; Pei R; Le ME; Borisov O; Piper R; Liu YD; Petty K; Apostol I; Flynn GC
    MAbs; 2013; 5(4):608-13. PubMed ID: 23751615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluctuations in dissolved oxygen concentration during a CHO cell culture process affects monoclonal antibody productivity and the sulfhydryl-drug conjugation process.
    Hippach MB; Schwartz I; Pei J; Huynh J; Kawai Y; Zhu MM
    Biotechnol Prog; 2018 Nov; 34(6):1427-1437. PubMed ID: 30207642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding mAb aggregation during low pH viral inactivation and subsequent neutralization.
    Wälchli R; Ressurreição M; Vogg S; Feidl F; Angelo J; Xu X; Ghose S; Jian Li Z; Le Saoût X; Souquet J; Broly H; Morbidelli M
    Biotechnol Bioeng; 2020 Mar; 117(3):687-700. PubMed ID: 31784982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining process design space for monoclonal antibody cell culture.
    Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
    Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and characterization of CHO host cell protease-induced fragmentation of a recombinant monoclonal antibody during production process development.
    Yang B; Li W; Zhao H; Wang A; Lei Y; Xie Q; Xiong S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1112():1-10. PubMed ID: 30836312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated continuous production of recombinant therapeutic proteins.
    Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
    Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of thioredoxin reduction of allosteric disulfide bonds on the therapeutic potential of monoclonal antibodies.
    Gurjar SA; Wheeler JX; Wadhwa M; Thorpe R; Kimber I; Derrick JP; Dearman RJ; Metcalfe C
    J Biol Chem; 2019 Dec; 294(51):19616-19634. PubMed ID: 31727737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simple and efficient purification platform for monoclonal antibody production based on chromatin-directed cell culture clarification integrated with precipitation and void-exclusion anion exchange chromatography.
    Chen Q; Abdul Latiff SM; Toh P; Peng X; Hoi A; Xian M; Zhang H; Nian R; Zhang W; Gagnon P
    J Biotechnol; 2016 Oct; 236():128-40. PubMed ID: 27568167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A predictive high-throughput scale-down model of monoclonal antibody production in CHO cells.
    Legmann R; Schreyer HB; Combs RG; McCormick EL; Russo AP; Rodgers ST
    Biotechnol Bioeng; 2009 Dec; 104(6):1107-20. PubMed ID: 19623562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scale-down model qualification of ambr® 250 high-throughput mini-bioreactor system for two commercial-scale mAb processes.
    Manahan M; Nelson M; Cacciatore JJ; Weng J; Xu S; Pollard J
    Biotechnol Prog; 2019 Nov; 35(6):e2870. PubMed ID: 31207168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.